Form 4: Planet Labs Director Carl Bass Sells Shares, Corrects Option Dates

Planet Labs Director Carl Bass exercised stock options and immediately sold the acquired shares, while also correcting previously misreported option expiration dates.

Summary

• Carl Bass, a Director at Planet Labs PBC, executed a transaction on October 6, 2025, involving the exercise of stock options and subsequent sale of Class A Common Stock.
• Bass acquired 376,748 shares of Class A Common Stock by exercising options at a price of $2.33 per share.
• Immediately following the acquisition, Bass disposed of the same 376,748 shares of Class A Common Stock at a weighted average price of $15.669 per share.
• After these transactions, Carl Bass beneficially owns 317,530 shares of Class A Common Stock directly.
• The filing corrects administrative errors from a previous Form 4 filed on December 9, 2021, regarding the expiration dates of two stock options.
• One stock option's expiration date was corrected from 5/4/2031 to 5/4/2026, and another from 6/29/2031 to 11/6/2029.
• A Power of Attorney document, dated August 29, 2025, designates Stephen Spivey, LeeAnn Linck, and Thomas Murphy to prepare and file SEC reports on behalf of Carl Bass.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction (exercise and sell-to-cover or diversification) which is common. The correction of past administrative errors is a minor negative, but the overall impact is neutral as it's a personal transaction rather than a company operational update.

Positives

• Carl Bass realized a significant gain from exercising stock options at $2.33 and selling shares at a weighted average price of $15.669.

Negatives

• The filing indicates administrative errors in a previous Form 4 regarding stock option expiration dates, requiring correction.
• A director selling a substantial number of shares, even if pre-planned, can sometimes be perceived negatively by investors.

Risks

• The correction of administrative errors in previous SEC filings could raise minor concerns about internal reporting accuracy.
• Insider selling, even if routine or pre-planned, might be interpreted by some investors as a lack of confidence, potentially impacting stock sentiment.

Future Outlook

This filing is a report of past insider transactions and does not contain forward-looking statements or guidance regarding the company's future performance.

Industry Context

This filing reports an individual insider transaction and does not provide broader industry context or trends. It reflects a director's personal equity management within Planet Labs PBC.

Corporate Governance

Stakeholder Impact

• Shareholders: May note the director's sale of shares, which could be interpreted in various ways depending on individual investment strategies and market sentiment. The transaction was executed under a Rule 10b5-1 plan, indicating it was pre-planned.

Key Dates

Recommendation

This Form 4 reports a director's exercise of stock options and subsequent sale of shares, which is a common occurrence for insiders managing their equity compensation. While insider selling can sometimes be viewed cautiously, this transaction appears to be part of a pre-planned strategy (Rule 10b5-1 plan indicated) and does not inherently signal a change in the company's fundamental outlook. The corrections to past administrative errors are minor. Therefore, this filing alone does not provide sufficient information to warrant a strong buy or sell recommendation, and a 'hold' stance is appropriate, pending further operational or financial updates from the company.

Keywords

Planet Labs, PL, Carl Bass, Form 4, Insider Trading, Stock Options, Share Sale, Director, SEC Filing